
|Articles|April 1, 2005
- Volume 0 0
ACE Inhibitors Lower Pneumonia Threat
Advertisement
Patients who have had a stroke can ward off the risk of pneumonia withangiotensin-converting enzyme (ACE) inhibitors. For the study, theresearchers evaluated the risk of pneumonia in >1000 patients who had hada stroke. The patients involved in the 35-month study were given 1 of 3 treatments:ACE inhibitors, other blood pressure drugs, or a placebo. The datashowed 2.8% of the ACE inhibitor group developed pneumonia, comparedwith 8.5% of the patients in the other 2 groups. (The findings were reportedin Neurology, February 9, 2005.)
Articles in this issue
about 21 years ago
Internet Prescribing 2005about 21 years ago
COMPOUNDING HOTLINEabout 21 years ago
Breakfast Cereals Take a Step in the Right Directionabout 21 years ago
Refined Carbs Cause Obesityabout 21 years ago
Obesity Problematic for Young Transplant Patientsabout 21 years ago
High BMI Linked to Dementiaabout 21 years ago
When Does Compounding Become Manufacturing?about 21 years ago
Talking to Your Diabetes Patients About Fiberabout 21 years ago
Counseling Guide for Avoiding Asthma Triggersabout 21 years ago
RA Drug Does Not Alter Cholesterol RatioAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
3
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5






































































































































